|
|
|
 
 
 
 
|
|
|
|
|
||
|
| ||||
| ||||
| ||||
| ||||
| ||||
|
|
|
Two new chemicals may help fight HIV: Study
Two chemical compounds may help the immune systems of HIV-infected people fight AIDS without invasive gene therapy, US scientists have said.
The new research, presented at a symposium on HIV/AIDS here, was conducted by researchers at the University of California, Los Angeles (UCLA) AIDS Institute, reported Xinhua.
The researchers said their findings demonstrated that the new chemicals activate telomerase, a protein that boosts immune cells'' ability to divide, enabling them to continue destroying HIV-infected cells.
But the researchers did not point out the components of the chemicals, partly because the study was sponsored by Geron, a bio-pharmaceutical firm that also provided the compounds.
Said Rita Effros, a professor at UCLA medical school who led the study: "The immune cells that fight HIV naturally produce telomerase during the infection's early phase, but stop once HIV becomes a chronic condition.
"The two compounds switched telomerase back on in the cells," Effros said.
Earlier research by the UCLA team showed that inserting the telomerase gene into the immune cells of an HIV-infected person prevented the cells from aging prematurely.
The telomerase enabled the immune cells to divide indefinitely, stimulated their production of a viral-fighting molecule and prolonged their power to kill HIV-infected cells.
In this study, the scientists isolated immune cells from the blood of HIV-infected persons and cultured the cells with the chemical compounds. They found that the compounds produced the same three changes in the cells as those created by the gene therapy.
"We discovered we didn''t need to use gene therapy to reactivate the telomerase and strengthen the immune system's capacity to stave off HIV," said Effros.
"We were thrilled to see we could create the same changes in the cells without relying on an invasive procedure."
Immune cells that battle HIV must constantly divide in order to continue performing their protective functions.
The massive amount of division prematurely shortens the ends of these cells, also known as telomeres, ultimately exhausting the immune system.
Previous research showed that telomerase rejuvenates the telomeres and allows the immune cells to remain youthful and active as they replicate under HIV's attack.
Drugs that activate telomerase also offer therapeutic potential for a wide spectrum of degenerative diseases and chronic conditions in which cellular ageing plays a role.
"I''m really excited by our findings. This progress moves us one step closer to drugs that work by switching telomerase on permanently and keeping the immune cells young and strong in their fight against infection," Effros said.
"These therapies are also easier to develop than gene-therapy drugs," she added.
TECHNOLOGY ARTICLES
|
|
| Click here to get ad specs and place your ad or Click here to contact the advertisement department |
Send Letters to the Editor |
Add RSS headlines